NCM Boston | Oxford Nanopore Technologies
NCM Boston
NCM Boston
A
)
Alex KneubehlBaylor College of Medicine, USA
)
Anne-Sophie LebreCHU Reims, France
)
Ailsa MacCalmanUniversity of Exeter, UK
)
Anastasia McKinlayIndiana University & HHMI, USA
)
Ana PeresThe University of North Carolina at Chapel Hill, USA
)
Aaron VinyColumbia University Irving Medical Center, USA
)
)
)
)
)
)
)
J
)
Justin BeckerDana-Farber Cancer Institute & Massachusetts General Hospital, USA
)
Jack ColicchioSound Agriculture, USA
)
J. (Gus) GustafsonUniversity of Washington, USA
K
)
Karine ChoquetUniversity of Sherbrooke, Canada
)
Kamil KhanipovThe University of Texas Medical Branch, USA
L
)
Lucia DaxingerLeiden University Medical Center, Netherlands
)
Lantana GrubVanderbilt University, USA
)
Laura KamenetzkyCONICET, Argentina
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Stephanie Chrysanthou
)
- Job title
- Institution
- Memorial Sloan Kettering Cancer Center, USA
- Biography
Stephanie Chrysanthou leads the R&D team in the Integrated Genomics Operation facility at Memorial Sloan Kettering Cancer Center, USA. Her goal is to adopt and optimize new genomic technologies to enable basic, clinical and translational projects across the Cancer Center. One of her research interests includes optimizing nanopore sequencing methodologies for bulk and single-cell analysis to detect structural variants and transcript isoforms in cancer patient samples. Previously, during her doctoral and post-doctoral studies at the University of Cambridge, UK and Albert Einstein College of Medicine, New York, she worked on the epigenetic mechanisms of early mammalian embryonic development.